At least 21 Indian companies with a market cap of over INR 5bn ($66m) saw their profits decline in each of the past four quarters and their...

Nykaa has faced massive selloff off late as Street dumped shares of richly valued new-age companies against the backdrop of Fed rate hikes,...

Net revenue, however, rose to Rs 399.19 crore in the third quarter as compared with Rs 310.26 crore in the same period of 2020-21, Morepen ...

"With massive increase in active pharmaceutical ingredient (API) demand globally and more particularly with frequent supply disruptions fro...

Its net revenue stood at Rs 388.31 crore in the quarter under consideration, up 50 per cent against Rs 258.97 crore a year ago, Morepen Lab...

The smallcap pharma scrip has been thumping rock and roll over the past few weeks.

The drug firm's consolidated net profit came in at Rs 26.76 crore for the quarter ended March 31.

Hindustan Unilever, Titan and Bajaj Auto, Ambuja Cements, Motherson Sumi, Bajaj Holdings, Shriram Transport, AU SFB, IndiaMart InterMesh an...

So far this week, Nectar Life has gained 36 per cent, Morepen has risen 30 per cent, Panacea has moved up 28 per cent Suven Life has advanc...

Consolidated total revenue of the company stood at Rs 310.26 crore for the quarter under consideration. It was Rs 234.65 crore for the same...

Its consolidated total revenue stood at Rs 208.38 crore for the quarter under consideration.

Probiotics gain demand in the new millennium but there is still a lot of grey area around the science of ingesting good bacteria.

Let's check out what all might matter to Dalal Street on Tuesday.

The Sensex rallied over 340 points, and Nifty breached the 11,200 mark for the first time today.

In my view, Greenply doesn’t have solid growth momentum in the last five years.

Indian equity benchmarks Nifty and Sensex extended the losses for the second session on Wednesday.

Every week, an expert selected by ET answers queries from our readers on stocks